This Article Abstract Full Text (PDF) All Versions of this Article: jhc.5A6663.2005v1 54/1/47    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Frederiks, W. M. Articles by Cascante, M. Search for Related Content PubMed PubMed Citation Articles by Frederiks, W. M. Articles by Cascante, M. Social Bookmarking                      What's this?

Improved Localization of Glucose-6-phosphate Dehydrogenase Activity in Cells with 5-Cyano-2,3-ditolyl-tetrazolium Chloride as Fluorescent Redox Dye Reveals its Cell Cycle–dependent Regulation

Wilma M. Frederiks, Jan van Marle, Carel van Oven, Begonya Comin-Anduix and Marta Cascante

Academic Medical Center, University of Amsterdam, Department of Cell Biology and Histology, Amsterdam, The Netherlands (WMF,JVM,CVO); Department of Surgery, University of California at Los Angeles, Los Angeles, CA (BCA); and Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain (MC)

Correspondence to: Wilma M. Frederiks, PhD, Department of Cell Biology and Histology, Academic Medical Center, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. E-mail: w.m.frederiks{at}amc.uva.nl

	Summary

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

 
Since the introduction of cyano-ditolyl-tetrazolium chloride (CTC), a tetrazolium salt that gives rise to a fluorescent formazan after reduction, it has been applied to quantify activity of dehydrogenases in individual cells using flow cytometry. Confocal laser scanning microscopy (CLSM) showed that the fluorescent formazan was exclusively localized at the surface of individual cells and not at intracellular sites of enzyme activity. In the present study, the technique has been optimized to localize activity of glucose-6-phosphate dehydrogenase (G6PD) intracellularly in individual cells. Activity was demonstrated in cultured fibrosarcoma cells in different stages of the cell cycle. Cells were incubated for the detection of G6PD activity using a medium containing 6% (w/v) polyvinyl alcohol, 5 mM CTC, magnesium chloride, sodium azide, the electron carrier methoxyphenazine methosulphate, NADP, and glucose-6-phosphate. Before incubation, cells were permeabilized with 0.025% glutaraldehyde. Fluorescent formazan was localized exclusively in the cytoplasm of fibrosarcoma cells. The amount of fluorescent formazan in cells increased linearly with incubation time when measured with flow cytometry and CLSM. When combining the Hoechst staining for DNA with the CTC method for the demonstration of G6PD activity, flow cytometry showed that G6PD activity of cells in S phase and G2/M phase is 27 ± 4% and 43 ± 4% higher, respectively, than that of cells in G1 phase. CLSM revealed that cells in all phases of mitosis as well as during apoptosis contained considerably lower G6PD activity than cells in interphase. It is concluded that posttranslational regulation of G6PD is responsible for this cell cycle–dependent activity. (J Histochem Cytochem 54:47–52, 2006)

Key Words: glucose-6-phosphate dehydrogenase • cyano-ditolyl-tetrazolium chloride • tetrazolium salt • confocal laser scanning microscopy • cell cycle

	Introduction

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

 
APPROXIMATELY 40 YEARS AGO, tetrazolium salts were introduced to demonstrate dehydrogenase activities in tissue sections with the formation of a colored precipitate, formazan (Butcher and Chayen 1965; Gahan and Kalina 1968; Altman 1969). Tetranitro BT and nitro BT were the best tetrazolium salts to be used for quantitative purposes, whereas (methoxy)phenazine methosulphate was the exogenous electron carrier of choice (Henderson and Loveridge 1981; Kugler 1982; Van Noorden and Butcher 1984). The histochemical assays appeared to be quantitative as was established by comparing cytophotometric data of absorbance of formazan in sections and individual cells with spectrophotometric measurements of NADPH produced by glucose-6-phosphate dehydrogenase (G6PD) activity in rat livers (Van Noorden et al. 1984). For flow cytometric analysis of enzyme activities in cells as well as localization of formazan in cells with the use of confocal laser scanning microscopy (CLSM) there is a need for tetrazolium salts which give rise to fluorescent formazans (Boonacker and Van Noorden 2001). For that purpose, tetrazolium salts have been developed with these properties such as 2-(4-iodophenyl)-3-4-nitrophenyl-2H-tetrazolium chloride and cyano-ditolyl-tetrazolium chloride (CTC) (Stellmach 1984; Langer 1985; Raap 1986; Seidler 1991).

Because CTC is commercially available (Polysciences; Warrington, PA), it has been applied, for example, to visualize respiring bacteria (Rodriguez et al. 1992; Schaule et al. 1993). In contrast to eukaryotic cells, bacteria are permeable for CTC, which allows the quantification of metabolic activity in living bacteria (Bartosch et al. 2003). Moreover, it has been demonstrated that CTC can be used to quantify activity of various dehydrogenases in individual cells using flow cytometry (Severin and Seidler 1992,1998; Huang and Severin 1993; Huang et al. 1994). By a combined analysis of CTC-formazan and nuclear DAPI fluorescence, cellular enzyme activity was studied in relation with the cell cycle (Severin and Seidler 1992,1998; Huang and Severin 1993). For this purpose, cells were permeabilized to allow the entry of compounds in the incubation media into cells (Huang and Severin 1993; Severin and Seidler 1998). CLSM was used to localize enzyme activities with CTC (Severin and Seidler 1998). This study clearly demonstrated that the fluorescent formazan was exclusively localized at the surface of cells, although cells had been incubated for the detection of intracellular dehydrogenase activities.

Recently, we found that human colon cancer (HT29) cells in culture express a distinct heterogeneity with respect to G6PD activity (Cascante et al., unpublished data). We hypothesized that G6PD activity in these cells was regulated in relation with cell cycle. For that purpose, we optimized the technique with CTC as introduced by Severin and Seidler (1992) to localize and quantify G6PD activity in individual cells using flow cytometry and CLSM.

	Materials and Methods

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

 
Cell Line
BN175 cells were derived from a spontaneous sarcoma in Brown Norway rats (Marquet et al. 1984). It is a rapidly growing and metastasizing soft tissue sarcoma. The cells were cultured at 37C in RPMI 1640 Dutch modification medium (RMPI; Life Technologies BV, Breda, The Netherlands) supplemented with 5% fetal calf serum, 2 mM glutamine (Life Technologies), 100 IU penicillin/ml and 100 µg streptomycin/ml (Life Technologies). The duplication time of the sarcoma cells was 21.6 hr. Cells were grown until 70–90% confluency, washed with PBS and, after detachment with 0.05% (w/v) trypsin and 0.02% (w/v) EDTA in PBS and centrifugation (250 x g for 5 min at room temperature), a single-cell suspension was obtained with a viability of at least 95%. Viability was tested with trypan blue staining.

Incubation of Cells
To permeabilize cells for compounds in the incubation medium necessary to demonstrate G6PD activity, cells were treated with 0.025% glutaraldehyde as described previously (Van Noorden and Vogels 1985; Frederiks and Vreeling-Sindelárová 2001,2002; Schellens et al. 2003). Before permeabilization, cells were incubated in 0.5 ml of a solution of 20 mM NADP⁺ (Boehringer; Mannheim, Germany) in 100 mM phosphate buffer, pH 7.4, for 10 min at 4C to protect the active site of G6PD against inactivation by glutaraldehyde.After centrifugation (250 g, 4C, 5 min) cells, were permeabilized by adding 5 ml of a freshly prepared solution containing 0.025% (v/v) glutaraldehyde (Merck; Darmstadt, Germany) in 100 mM phosphate buffer, pH 7.4. Permeabilization was performed for 30 min at room temperature under continuous rotation of the tubes. The procedure was stopped by washing the cells three times for 1 min with 3 ml 100 mM phosphate buffer, pH 7.4, at 4C followed by rapid centrifugation at 250 x g. The cells were suspended in 0.5 ml of the same buffer.

The enzyme histochemical procedure was based on the tetrazolium salt method as described by Van Noorden and Frederiks (1992) and Frederiks and Vreeling-Sindelárová (2001). The incubation medium for the demonstration of G6PD activity contained 6% (w/v) polyvinyl alcohol (PVA; average molecular weight 70,000–100,000; Sigma, St Louis, MO) in 100 mM phosphate buffer, pH 7.4, 10 mM glucose-6-phosphate (Boehringer), 0.8 mM NADP⁺ (Boehringer), 0.32 mM 1-methoxyphenazine methosulphate (Serva; Heidelberg, Germany), 5 mM MgCl₂, 5 mM sodium azide and 5 mM 5-cyano-2,3-ditolyl tetrazolium chloride (CTC; Polysciences). CTC was added after being dissolved in a heated mixture of dimethylformamide and ethanol (final dilution of each solvent in the medium was 2% v/v). The medium was freshly prepared immediately before incubation. Cell suspensions (100 µl) were added to the media (1 ml) for demonstration of G6PD activity. The incubation was carried out for 5, 10, 15, or 20 min at room temperature under continuous rotation. Control reactions were performed in the same incubation medium lacking glucose-6-phosphate and NADP⁺. Other control reactions were performed such as incubation with media lacking glucose-6-phosphate, media lacking NADP⁺, and complete media in the presence of 10 mM dehydroepiandrosterone (Sigma). The reaction was stopped by adding 5 ml 100 mM phosphate buffer, pH 7.4, at 4C. The cells were washed three times with the same buffer, spun down at 1000 x g, and finally resuspended in 1 ml buffer. To stain DNA in cells, 10 µl Hoechst 33,342 solution (0.5 mg dissolved in 1 ml distilled water) was added to 1 ml cell suspension.

To compare the localization of CTC-formazan in cells incubated according to our procedure with the method described by others (Severin and Seidler 1998), cells were incubated with media containing 1 mM CTC instead of 5 mM and in media that lack 6% PVA.

Microscopic observations on incubated cells were performed by bringing the cells on glass slides, covering, and sealing with nail polish.

In addition to the incubations of cells in suspension, glutaraldehyde-treated cells were brought on glass slides and were incubated with incubation media on the stage of the microscope to follow the formation of final reaction product in time.

The localization of final reaction product in glutaraldehyde-treated cells because of G6PD activity was compared with the localization of CTC-formazan in untreated cells. For that purpose, glutaraldehyde-treated cells and untreated cells were brought on glass slides, dried, and incubated for the demonstration of G6PD activity. The incubation media were prepared as mentioned previously, containing 18% PVA instead of 6% PVA, which was applied previously on unfixed cells or cryostat sections (Van Noorden and Frederiks 1992). After incubation for 20 min at room temperature, cells were rinsed with phosphate buffer, pH 5.0, to remove the incubation media. Then cells were embedded in Vectashield.

Flow Cytometry
Amounts of CTC-formazan and Hoechst-DNA were determined in individual sarcoma cells using bivariate flow cytometry (FACS Vantage; Becton Dickinson, San Jose, CA). Excitation was performed at a wavelength of 488 nm and 350 nm, and fluorescence was measured with band pass filters 619–641 nm and 402–446 nm for CTC-formazan and Hoechst-DNA, respectively. Fluorescence intensities of CTC-formazan were determined in 5–10,000 cells in G1, S, and G2/M phase based on DNA content in three individual experiments.

Confocal Laser Scanning Microscopy
Confocal microscopy was performed with an SP2 confocal system (Leica; Mannheim, Germany). A 63x NA 1.32 HCX PL Apo CS oil objective was used in combination with a zoom factor of four. Stacks through the cells were made with a step size of 0.28 µm. The setting of the pinhole was corresponding with 1 Airy disc to ensure optimal resolution in Z. The final voxel size was 0.12 x 0.12 x 0.28 µm. Images (512 x 512) were adjusted to the full (8 bit) dynamic range. Hoechst was imaged with 364 nm excitation and mirror setting for the detection at 410–460 nm, whereas the CTC-formazan was imaged using 488 nm excitation and detection at 610–690 nm.

Final images of the cells are presented as maximum intensity projections.

	Results

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

 
Localization of final reaction product (formazan) in BN175 fibrosarcoma cells incubated for the demonstration of G6PD activity with 5 mM CTC as tetrazolium salt in the presence of 6% PVA is shown in Figure 1A . Crystalline fluorescent final reaction product was exclusively found in the cytoplasm of the cells. The nucleus did not show any formazan, which could be concluded from the images of individual sections obtained with CLSM. Reaction product was not present at the surface of the plasma membrane. When cells were incubated for the demonstration of G6PD activity with 1 mM CTC in the absence of PVA, reduced amounts of formazan were found only at the surface of the plasma membrane. This suggests that 5 mM CTC and 6% PVA are essential for the detection of G6PD activity intracellularly. When cells were incubated in the absence of substrate and coenzyme, in the absence of substrate and in the presence of NADP⁺, or in the presence of substrate and in the absence of NADP⁺, crystalline fluorescent final reaction product was not generated in the cytoplasm or at the surface of the plasma membrane. The amount of formazan produced after incubation for the demonstration of G6PD activity was largely reduced when the incubation was performed in the presence of dehydroepiandrosterone. The localization of final reaction product was similar in cells that were permeabilized with glutaraldehyde and cells that were made permeable by drying on glass slides.

View larger version (63K): [in this window] [in a new window]   Figure 1 Micrographs of fluorescent final reaction product in the cytoplasm of fibrosarcoma cells in interphase (A), prophase (B), metaphase (C), anaphase (D), telophase (E), and apoptosis (F) after incubation for the demonstration of glucose-6-phosphate dehydrogenase activity with cyano-ditolyl-tetrazolium chloride as tetrazolium salt. Final reaction product (formazan) is shown as red fluorescence and DNA is stained blue. Bar = 4 µm.

View larger version (12K): [in this window] [in a new window]   Figure 2 Relationships between the amount of fluorescent final reaction product (formazan) and incubation time in interphase fibrosarcoma cells incubated for the demonstration of glucose-6-phosphate dehydrogenase activity with cyano-ditolyl-tetrazolium chloride as tetrazolium salt as detected in four different individual cells using confocal laser scanning microscopy (A) during incubation and flow cytometry (B) with end-point measurement.

Cells in G2 and M phase cannot be distinguished based on their DNA content using flow cytometry. Therefore, the amount of fluorescent final reaction product in interphase cells and mitotic cells was investigated using CLSM. Figures 1B–1E show cells in prophase, metaphase, anaphase, and telophase, respectively. Final reaction product was present in small amounts in cells in these mitotic phases as compared with cells in G1 phase. Cells in apoptosis showing nuclear fragmentation also contained only small amounts of final reaction product (Figure 1F).

	Discussion

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

 
The present study has shown that G6PD activity can be localized in the cytoplasm of individual cells as a fluorescent formazan when using CTC. Fluorescent formazans are suitable for precise microscopical localization with CLSM and for combined analysis with other fluorescent markers with CLSM and flow cytometry. CLSM clearly showed that fluorescent final reaction product from G6PD activity was localized intracellularly in BN175 fibrosarcoma cells (Figure 1), which is in contrast with data of Huang and Severin (1993) and Severin and Seidler (1998), who demonstrated fluorescent formazan predominantly on the cell surface after incubation for the demonstration of the activity of various dehydrogenases. The main differences between our procedure and that of Huang and Severin (1993) are that 6% polyvinyl alcohol was added to the incubation media and that 5 mM instead of 1 mM CTC was used in the incubation media, allowing a more precise intracellular localization.

In the present study, we permeabilized cells with 0.025% glutaraldehyde as was done previously for the demonstration of G6PD activity in individual human erythrocytes and rat liver parenchymal cells (Van Noorden et al. 1982,1989; Van Noorden and Vogels 1985; Vogels et al. 1986; Jonges et al. 1989; Frederiks and Vreeling-Sindelárová 2001). We have shown that treatment with 0.025% glutaraldehyde in combination with NADP protection reduced G6PD activity in liver parenchymal cells by 25% only (Frederiks and Vreeling-Sindelárová 2001) and that it was localized at membranes of granular endoplasmic reticulum, in peroxisomes and in the cytoplasm of liver parenchymal cells (Frederiks and Vreeling-Sindelárová 2001; Schellens et al. 2003). These findings were in agreement with biochemical data and confirmed the character of G6PD as a loosely bound enzyme. Addition of 6% PVA to the incubation media as used earlier to demonstrate G6PD activity in erythrocytes and liver parenchymal cells may prevent leakage of loosely bound proteins from the cells and thus to fake localization at the surface of cells. Moreover, by increasing the concentration of the tetrazolium salt from 1 to 5 mM in the incubation media, the capturing reaction is accelerated, giving rise to precipitation of the final reaction product at the site of enzyme activity (Van Noorden and Frederiks 1992). We conclude that addition of PVA to the incubation medium and the use of 5 mM CTC in combination with permeabilization of cells enabled a precise intracellular localization of G6PD activity in individual cells in the present study.

The significance of extracellular localization of fluorescent formazan on the surface of cells as a consequence of reduction of CTC has been investigated in the past. Gorog and Kovacs (1995) suggested that generation of reactive oxygen species on the surface of platelets reduced CTC, whereas Bernas and Dobrucki (1999,2000) indicated that in the absence of a plasma membrane-permeable electron carrier, only enzymes or reducing compounds associated with plasma membranes were involved in the reduction of CTC. Severin and Seidler (1998) interpreted the CTC-formazan produced by permeabilized cells and localized at the plasma membrane to be derived from intracellular dehydrogenase activities dependent on the specific substrate added. Conclusions were drawn on enzyme activities in single cells on the basis of quantitative analysis of individual cells with flow cytometry (Severin and Seidler 1992; Huang and Severin 1993; Huang et al. 1994). However, in the present study, it is concluded that fibrosarcoma cells did not contain reducing compounds on their plasma membranes and that intracellular enzyme activities produced fluorescent formazan intracellularly under optimized incubation conditions.

Furthermore, we have shown that the reaction rate of intracellular G6PD activity in fibrosarcoma cells as determined with flow cytometry and CLSM is linear with time. Therefore, we conclude that G6PD activity in cells in different phases of the cell cycle may be compared quantitatively.

We have found that G6PD activity increased in cells in S phase as compared with cells in G1 phase. Severin and Seidler (1998) have shown that the activity of NAD(P)H oxidoreductase was twice higher in G2/M phase than in G0/G1 or early S phase in an endothelial cell line. It was assumed that most, if not all proteins are doubled in amounts at the end of the S phase before mitosis. However, we found only a 30–40% increase in G6PD activity in G2/M phase as compared with G1 phase, which may be due to the presence of mitotic cells in this fraction. To our surprise, we found an abrupt decrease of G6PD activity in cells in mitosis. The rapid change indicates posttranslational regulation of G6PD as has been demonstrated before in other conditions (Swezey and Epel 1986; Stanton et al. 1991; Zhang et al. 2000; Jain et al. 2004). Decreased G6PD activity was not only observed in cells in mitosis, but also in cells in apoptosis. Tian et al. (1999) demonstrated that reduced G6PD activity in apoptotic cells was accompanied by the appearance of a 46-kDa fragment of G6PD, suggesting proteolytic cleavage of G6PD during apoptosis. Whether this is a common feature of cells in apoptosis and possibly also mitosis has to be established. When considering the major functions of G6PD, it can be assumed that the capacity of synthesis of nucleotides and of maintenance of the intracellular redox state is diminished during mitosis and apoptosis. More studies are needed to unravel the mechanism of inactivation and its functional significance.

In conclusion, CTC is a suitable tetrazolium salt to study dehydrogenase and oxidase activities in individual cells using flow cytometry and CLSM, provided proper procedures are performed to permeabilize cells, to minimize inactivation of enzymes and to optimize precision of localization. The use of CTC for the demonstration of enzyme activities also allows combination with other fluorescent probes such as DNA stains, markers of different organelles, and fluorescent immunolabeling of proteins and other macromolecules.

	Acknowledgments

 
The authors are grateful to Prof. Dr. C.J.F. Van Noorden for fruitful discussions and critical review of the manuscript and to Ms. T.M.S. Pierik for careful preparation of the manuscript.

	Footnotes

 
Received for publication February 24, 2005; accepted July 12, 2005

	Literature Cited

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

 

Altman FP (1969) The use of eight different tetrazolium salts for a quantitative study of pentose shunt dehydrogenation. Histochemie 19:363–374

Bartosch S, Mansch R, Knötsch K, Bock E (2003) CTC staining and counting of actively respiring bacteria in natural stone using confocal laser scanning microscopy. J Microbiol Meth 52:75–84

Bernas T, Dobrucki J (1999) Reduction of a tetrazolium salt, CTC, by intact HepG2 human hepatoma cells: subcellular localisation of reducing systems. Biochim Biophys Acta 1451:73–81

Bernas T, Dobrucki JW (2000) The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC. Arch Biochem Biophys 380:108–116

Boonacker E, Van Noorden CJF (2001) Enzyme cytochemical techniques for metabolic mapping in living cells, with special reference to proteolysis. J Histochem Cytochem 49:1473–1486

Butcher RG, Chayen J (1965) Oxidation of L-ascorbic acid by cells of carcinoma of the human cervix. Nature 207:992–993

Frederiks WM, Vreeling-Sindelárová H (2001) Localization of glucose-6-phosphate dehydrogenase activity on ribosomes of granular endoplasmic reticulum, in peroxisomes and peripheral cytoplasm of rat liver parenchymal cells. Histochem J 33:345–353

Frederiks WM, Vreeling-Sindelárová H (2002) Ultrastructural localization of xanthine oxidoreductase activity in isolated rat liver cells. Acta Histochem 104:29–37

Gahan PB, Kalina M (1968) The use of tetazolium salts in the histochemical demonstration of succinic dehydrogenase activity in plant tissues. Histochemie 14:81–88

Gorog P, Kovacs IB (1995) Lipid peroxidation by activated platelets: a possible link between thrombosis and atherogenesis. Atherosclerosis 115:121–128

Henderson B, Loveridge N (1981) Intermediate electron-acceptors in quantitative cytochemistry. Comparison of phenazine methosulphate and Meldola Blue. Histochemistry 72:617–623

Huang C-J, Severin E (1993) Enzyme activities of six different dehydrogenases in Ehrlich ascites cells measured by flow cytometry. Acta Histochem 94:33–45

Huang CJ, Severin E, Blum M (1994) Flow-cytometric determination of dehydrogenase activities in primary human gastrointestinal tumor cell lines. Anal Cell Pathol 6:93–103

Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, Loscalzo J, et al. (2004) Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 109:898–903

Jonges GN, Hagen H, Van Noorden CJF, Weening RS, Roos D (1989) Comparison between the chromate inhibition test and a cytochemical method for the determination of glucose-6-phosphate dehydrogenase deficiency in erythrocytes. Clin Chim Acta 181:135–141

Kugler P (1982) Quantitative dehydrogenase histochemistry with exogenous electron carriers (PMS, MPMS, MB). Histochemistry 75:99–112

Langer EM (1985) Demonstration of succinate dehydrogenase activity in ascites tumor cells using fluorescent tetrazolium salts. Acta Histochem 76:23–28

Marquet RL, Westbroek DL, Jeekel J (1984) Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int J Cancer 33:689–692

Raap AK (1986) Localization properties of fluorescence cytochemical enzyme procedures. Histochemistry 84:317–321

Rodriguez GG, Phipps D, Ishiguro K, Ridgway HF (1992) Use of a fluorescent redox probe for direct visualization of actively respiring bacteria. Appl Environ Microbiol 58:1801–1808

Schaule G, Flemming HC, Ridgway HF (1993) Use of 5-cyano-2,3-ditolyl tetrazolium chloride for quantifying planktonic and sessile respiring bacteria in drinking water. Appl Environ Microbiol 59:3850–3857

Schellens JPM, Vreeling-Sindelárová H, Frederiks WM (2003) Electron microscopical enzyme histochemistry on unfixed tissues and cells. Bridging the gap between LM and EM enzyme histochemistry. Acta Histochem 105:1–19

Seidler E (1991) The tetrazolium-formazan system: design and histochemistry. Prog Histochem Cytochem 24:1–86

Severin E, Seidler E (1992) Calibration of a flow cytometric assay of glucose-6-phosphate dehydrogenase activity. Cytometry 13:322–326

Severin E, Seidler E (1998) Flow cytometric assay of cytochemically demonstrated NAD(P)H oxidoreductase (diaphorase) activities. J Histochem Cytochem 46:761–766

Stanton RC, Seifter JL, Boxer DC, Zimmerman E, Cantley LC (1991) Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors. Correlation with increased enzymatic activity. J Biol Chem 266:12442–12448

Stellmach J (1984) Fluorescent redox dyes. 1. Production of fluorescent formazan by unstimulated and phorbol ester- or digitonin-stimulated Ehrlich ascites tumor cells. Histochemistry 80:137–143

Swezey RR, Epel D (1986) Regulation of glucose-6-phosphate dehydrogenase activity in sea urchin eggs by reversible association with cell structural elements. J Cell Biol 103:1509–1515

Tian W-N, Braunstein LD, Apse K, Pang J, Rose M, Tian X, Stanton RC (1999) Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol 276:C1121–C1131

Van Noorden CJF, Butcher RG (1984) Histochemical localization of NADP-dependent dehydrogenase activity with four different tetrazolium salts. J Histochem Cytochem 32:998–1004

Van Noorden CJF, Frederiks WM (1992) Enzyme Histochemistry. A Laboratory Manual of Current Methods. Oxford, BIOS

Van Noorden CJF, Vogels IMC (1985) A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. II. Further improvements of the staining procedure and some observations with glucose-6-phosphate dehydrogenase deficiency. Br J Haematol 60:57–63

Van Noorden CJF, Vogels IMC, James J, Tas J (1982) A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. I. Optimalization of the staining procedure. Histochemistry 75:493–506

Van Noorden CJF, Vogels IMC, Houtkooper JM, Fronik G, Tas J, James J (1984) Glucose-6-phosphate dehydrogenase activity in individual rat hepatocytes of different ploidy classes. I. Developments during postnatal growth. Eur J Cell Biol 33:157–162

Van Noorden CJF, Dolbaere F, Aten J (1989) Flow cytofluorometric analysis of enzyme reactions based on quenching of fluorescence by the final reaction product: detection of glucose-6-phosphate dehydrogenase deficiency in human erythrocytes. J Histochem Cytochem 37:1313–1318

Vogels IMC, Van Noorden CJF, Wolf BH, Saelman DE, Tromp A, Schutgens RB, Weening RS (1986) Cytochemical determination of heterozygous glucose-6-phosphate dehydrogenase deficiency in erythrocytes. Br J Haematol 63:401–405

Zhang Z, Apse K, Pang J, Stanton RC (2000) High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 275:40042–40047

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This Article Abstract Full Text (PDF) All Versions of this Article: jhc.5A6663.2005v1 54/1/47    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Frederiks, W. M. Articles by Cascante, M. Search for Related Content PubMed PubMed Citation Articles by Frederiks, W. M. Articles by Cascante, M. Social Bookmarking                      What's this?

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact